Home
About
Company
Careers
Technology
Pipeline
Collaboration
News
Investors
Contact
Menu
Home
About
Company
Careers
Technology
Pipeline
Collaboration
News
Investors
Contact
Search
Close
中文
Menu
中文
News
Home
>
News
News
Asieris Pharmaceuticals is invited to present at the China Bio Partnership Forum 2016
Scenes at the European Association of Urology (EAU) 2016 Congress
Interim results of China Phase II Clinical Trial of APL-1202 accepted for presentation
Asieris nominated as one of Jiangsu’s “Innovation and Entrepreneurship Top 60” SMEs
Asieris completed enrollment for its China Phase II Trial of APL-1202
Asieris won a Small to Medium-Size Technological Enterprise (SME) in Jiangsu
Dr. Kevin Pan was selected as a member of “113 Talent Program”
Dr. Yuh visited Nanjing iDatastat, the CRO for APL-1202’s China phase II trial
Asieris initiated TV interview for APL-1202 China phase 2 clinical trial
Asieris held an investigators’ meeting for APL-1202’s phase II clinical trial in China
« Previous
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Next »